Related Experiment Video
Updated: Feb 2, 2026

Measuring Composition of CD95 Death-Inducing Signaling Complex and Processing of Procaspase-8 in this Complex
Published on: August 2, 2021
Carney Complex
Crystal D C Kamilaris1, Fabio Rueda Faucz1, Antonis Voutetakis2
1Section on Endocrinology and Genetics & Endocrinology Inter-institute Training Program, Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD, USA.
Abstract:
Carney complex is a rare, autosomal dominant, multiple endocrine neoplasia and lentiginosis syndrome, caused in most patients by defects in the PRKAR1A gene, which encodes the regulatory subunit type 1α of protein kinase A. Inactivating defects of PRKAR1A lead to aberrant cyclic-AMP-protein kinase A signaling. Patients may develop multiple skin abnormalities and a variety of endocrine and non-endocrine tumors. Endocrine manifestations include primary pigmented nodular adrenocortical disease, that may cause Cushing syndrome, growth-hormone secreting pituitary adenoma or pituitary somatotropic hyperplasia which can result in acromegaly, as well as gonadal and thyroid tumors. Non-endocrine tumors associated with Carney complex include myxomas of the heart, breast, and other sites, psamommatous melanotic schwannomas, breast ductal adenomas, osteochondromyxomas, and a predisposition to a number of malignancies from adrenal to pancreatic and liver cancer.
Insights
Carney complex, a genetic disorder caused by PRKAR1A gene defects, leads to skin issues and various tumors. Understanding PRKAR1A gene function is crucial for managing this rare endocrine and lentiginosis syndrome.
Area of Science:
- Genetics
- Endocrinology
- Oncology
Background:
- Carney complex is a rare autosomal dominant disorder.
- It involves multiple endocrine neoplasia and lentiginosis.
- Most cases stem from defects in the PRKAR1A gene, impacting protein kinase A signaling.
Purpose of the Study:
- To summarize the genetic basis and clinical manifestations of Carney complex.
- To highlight the role of PRKAR1A gene defects.
- To detail the spectrum of endocrine and non-endocrine tumors associated with the syndrome.
Main Methods:
- Review of existing literature on Carney complex.
- Analysis of genetic defects in PRKAR1A.
- Compilation of reported clinical features and tumor types.
Main Results:
- PRKAR1A gene defects cause aberrant cyclic-AMP-protein kinase A signaling.
- Patients develop skin abnormalities, endocrine tumors (adrenal, pituitary, gonadal, thyroid), and non-endocrine tumors (myxomas, schwannomas, adenomas, osteochondromyxomas).
- Increased risk of malignancies including adrenal, pancreatic, and liver cancer.
Conclusions:
- PRKAR1A gene mutations are central to Carney complex pathogenesis.
- The syndrome presents with a wide array of neoplastic manifestations.
- Comprehensive management requires awareness of diverse endocrine and non-endocrine tumor risks.
Related Concept Videos
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Complex Numbers
Formation of Complex Ions
Complex Power
Complex power is defined as the multiplication of the voltage and the complex conjugate of the current. The magnitude of this power, known as apparent power, is measured in volt-amperes (VA). Notably, the angle of the complex power equates to the...
Complexation Equilibria: Factors Influencing Stability of Complexes

